Top Clinical Trials companies in Israel by Net Cash Used For Investing Activities

This ranking features the top 11 Clinical Trials companies in Israel ranked by Net Cash Used For Investing Activities, totalling a Net Cash Used For Investing Activities of USD 70.17 M, for January 15, 2025.

Israel

Clinical Trials
Net Cash Used For Investing Activities
#
Name
Net Cash Used For Investing Activities
 Reported Date
Stock Price
Change
 Price (30 days) Country
1
CGEN.TA

Compugen Ltd.

1

CGEN.TA
USD 35.51 M
Dec. 31, 2023 USD 1.85 10.75%

Israel
2
DRTS

Alpha Tau Medical Ltd.

2

DRTS
USD 18.68 M
Dec. 31, 2023 USD 4.00 8.11%

Israel
3
CMMB

Chemomab Therapeutics Ltd.

3

CMMB
USD 15.88 M
Dec. 31, 2023 USD 1.90 -4.04%

Israel
4
PPBT.TA

Purple Biotech Ltd.

4

PPBT.TA
USD 13.88 M
Dec. 31, 2023 USD 0.02 -1.36%

Israel
5
PRFX

PainReform Ltd.

5

PRFX
USD 5.99 M
Dec. 31, 2023 USD 2.74 -3.52%

Israel
6
NRSN

NeuroSense Therapeutics Ltd.

6

NRSN
USD 3.47 M
Dec. 31, 2023 USD 1.03 -0.96%

Israel
7
BLRX.TA

BioLineRx Ltd.

7

BLRX.TA
USD 1.44 M
Dec. 31, 2023 USD 0.01 -11.50%

Israel
8
GLMD

Galmed Pharmaceuticals Ltd.

8

GLMD
USD 800.00 K
Dec. 31, 2023 USD 2.82 -2.08%

Israel
9
CANF.TA

Can-Fite BioPharma Ltd.

9

CANF.TA
USD 498.00 K
Dec. 31, 2023 USD 0.01 0.04%

Israel
10
ENTX

Entera Bio Ltd.

10

ENTX
USD -17.00 K
Dec. 31, 2023 USD 2.36 -1.67%

Israel
11
ENLV.TA

Enlivex Therapeutics Ltd.

11

ENLV.TA
USD -25.97 M
Dec. 31, 2023 USD 1.16 -2.88%

Israel
Frequently Asked Questions
  • Which Clinical Trials company in Israel has the highest Net Cash Used For Investing Activities ?

    The Clinical Trials company in Israel with the highest Net Cash Used For Investing Activities is Compugen Ltd. (Tel Aviv Stock Exchange: CGEN.TA) at USD 35.51 M.

  • Which Clinical Trials company in Israel has the lowest Net Cash Used For Investing Activities ?

    The Clinical Trials company in Israel with the lowest Net Cash Used For Investing Activities is Enlivex Therapeutics Ltd. (Tel Aviv Stock Exchange: ENLV.TA) at USD -25.97 M.